细胞扩增市场规模、份额和成长分析（按产品、细胞类型、应用、最终用途和地区）- 产业预测 2025-2032

2023 年细胞扩增市场规模价值 304 亿美元，预计将从 2024 年的 335.3 亿美元成长到 2032 年的 734.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 10.3%。

细胞扩增市场正在经历显着的成长，这得益于细胞治疗处理解决方案的进步，这些解决方案简化了业务、降低了成本，同时提供了可靠的结果。主要企业正在扩大其产品组合，以满足全球对细胞和基因疗法日益增长的需求。转向一次性系统（SUS）可提高生产率，最大限度地降低交叉污染的风险，并有利于以较低的长期成本生产更高的细胞密度。 SUS 的日益普及支持了这一势头，进一步支持了细胞疗法在生命科学领域的普及。私人和政府组织的大力投资以及支持细胞疗法发展的倡议是市场的重要驱动力。此外，国际干细胞研究学会正在努力创造资金筹措机会，加强美国细胞扩增市场的上升趋势，预计未来几年该市场将以持续的复合年增长率成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

细胞扩增市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 耗材
  • 试剂 培养基 血清
  • 其他耗材
• 培养瓶及配件
  • 组织培养瓶
  • 生物反应器配件
  • 其他培养瓶及配件
• 装置
  • 自动化细胞扩增系统
  • 细胞计数器
  • 离心机
  • 生物反应器
  • 其他仪器

细胞扩增市场规模（按细胞类型和复合年增长率） (2025-2032)

• 市场概况
• 哺乳类
  • 人类
  • 干细胞（SC）
  • 成体干细胞
  • 胚胎干细胞
  • 诱导多功能细胞
  • 分化细胞
  • 动物
• 微生物
• 其他的

细胞扩增市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 生物製药
• 组织培养与工程
• 疫苗生产
• 药物开发
• 基因治疗
• 癌症研究
• 干细胞研究
• 其他的

细胞扩增市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 生物製药和生物技术公司
• 研究组织
• 细胞银行
• 其他的

细胞扩增市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（US）
• Becton, Dickinson and Company（US）
• Lonza Group（Switzerland）
• Corning Incorporated（US）
• Merck KGaA（Germany）
• Sartorius Stedim Biotech SA（Germany）
• Terumo Corporation（Japan）
• Miltenyi Biotec GmbH（Germany）
• Danaher Corporation（US）
• Stemcell Technologies Inc.（Canada）
• Beckman Coulter Inc.（US）
• Takara Bio Inc.（Japan）
• RepliCel Life Sciences（Canada）
• NexImmune Inc.（US）
• Celltainer Biotech BV（Netherlands）
• Repligen Corporation（US）
• Getinge AB（Sweden）
• Bio-Techne Corporation（US）
• PromoCell GmbH（Germany）
• Himedia Laboratories（India）

结论和建议

Cell Expansion Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 33.53 billion in 2024 to USD 73.46 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The cell expansion market is witnessing significant growth driven by advancements in cell therapy processing solutions, which streamline operations and reduce costs while delivering reliable results. Key players are expanding their product offerings to accommodate the surging global demand for cell and gene therapies. The shift towards single-use systems (SUS) enhances productivity, minimizing cross-contamination risks and facilitating higher cell density production at lower long-term costs. Increased adoption of SUS supports this momentum, further propelling cell therapy popularity within the life sciences sector. Robust investments from private and government organizations, coupled with initiatives supporting cell therapy development, are vital market drivers. Furthermore, the International Society for Stem Cell Research is working to create funding opportunities, reinforcing the upward trend in the US cell expansion market, projected to grow at a sustainable CAGR in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Expansion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Expansion Market Segments Analysis

Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented intobiopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Expansion Market

The rapid adoption of cell expansion techniques in biopharmaceutical development represents a significant growth catalyst for the market. Key products like monoclonal antibodies, vaccines, and cell-based therapies are dependent on efficient and scalable cell expansion processes. Additionally, the rising incidence of chronic illnesses and the growing global demand for personalized medicine are driving the need for high-quality biopharmaceuticals. This trend underscores the importance of advanced cell expansion methods, as they are crucial for producing the necessary biological materials to meet the evolving healthcare demands. As such, the cell expansion market is positioned for considerable growth in the coming years.

Restraints in the Cell Expansion Market

One significant restraint in the Cell Expansion market stems from the regulatory and ethical challenges associated with cell-based therapeutic technologies. The development and marketing of such cell-based products necessitate adherence to stringent regulatory guidelines, which can differ considerably from one region to another. Furthermore, ethical dilemmas surrounding the use of embryonic stem cells and gene-editing methods pose considerable barriers to research and development activities in this field. These factors collectively limit the pace of innovation and commercialization in the Cell Expansion market, making it imperative for stakeholders to navigate these complexities effectively.

Market Trends of the Cell Expansion Market

The cell expansion market is witnessing a significant trend towards the adoption of 3D cell culture and bioreactor technologies, as researchers and biopharmaceutical companies pivot from conventional 2D culture systems. This shift is driven by the enhanced ability of 3D cultures to more accurately replicate the physiological microenvironment of cells, thereby improving cell function, viability, and behavior. This innovation is particularly transformative in areas such as regenerative medicine, cancer research, and drug development, where more realistic cellular models can yield more reliable data and outcomes. As technology evolves, its integration into various applications is expected to propel market growth and expand its potential.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cell Expansion Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents, Media, & Serum
  • Other Consumables
• Culture Flasks and Accessories
  • Tissue Culture Flasks
  • Bioreactor Accessories
  • Other Culture Flasks and Accessories
• Instruments
  • Automated Cell Expansion Systems
  • Cell Counters
  • Centrifuges
  • Bioreactors
  • Other Instruments

Global Cell Expansion Market Size by Cell Type & CAGR (2025-2032)

• Market Overview
• Mammalian
  • Human
  • Stem Cells (SCs)
  • Adult SCs
  • Embryonic SCs
  • Induced Pluripotent SCs
  • Differentiated Cells
  • Animal
• Microbial
• Others

Global Cell Expansion Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biopharmaceuticals
• Tissue Culture & Engineering
• Vaccine Production
• Drug Development
• Gene Therapy
• Cancer Research
• Stem Cell Research
• Others

Global Cell Expansion Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Biopharmaceutical & Biotechnology Companies
• Research Institutes
• Cell Banks
• Others

Global Cell Expansion Market Size & CAGR (2025-2032)

• North America (Product, Cell Type, Application, End Use)
  • US
  • Canada
• Europe (Product, Cell Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius Stedim Biotech SA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RepliCel Life Sciences (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NexImmune Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltainer Biotech BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations